Levaggi R., Pertile P. (2021). A reply to “Who would benefit from average value-based pricing?”. HEALTH ECONOMICS, Volume 30(9), pp. 2284-2286. PubblicazioniPaolo Pertile
Bucciol A., Cavalli L., Pertile P., Polin V., Sommacal A. (2013). Redistribution at the Local Level: The Case of Public Childcare in Italy. University of Verona Department of Economics Working Paper 21/2013 (ISSN 2036-2919). Working PapersPaolo PertileAlessandro SommacalVeronica Polin
Gamba S., Magazzini L., Pertile P. (2021). R&D and market size: Who benefits from orphan drug legislation?. Journal of Health Economics, 80, 102522. PubblicazioniPaolo Pertile
Forster M., Brealey S., Chick S., Keding A., Corbacho B., Alban A., Pertile P., Rangan A. (2021). Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial. Clinical Trials, 18(6), 647-656. PubblicazioniPaolo Pertile
Levaggi R., Pertile P. (2020) Which valued-based price when patients are heterogeneous? Health economics, 29(8), 923-935. PubblicazioniPaolo Pertile
Levaggi R., Pertile P. (2020) Authors’ Reply to Garattini and Freemantle: “Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition”. Applied health economics and health policy, 18(3), 455-456. PubblicazioniPaolo Pertile
Gamba S., Pertile P., Vogler S.(2020) The impact of managed entry agreements on pharmaceutical prices. Health Economics, 29, 47-62. PubblicazioniPaolo Pertile
Gamba S., Magazzini L., Pertile P. (2019). R&D and market size: who benefits from orphan drug regulation?. Working Paper Series, Department of Economics, University of Verona. Working PapersPaolo Pertile
Levaggi R., Pertile P. (2019). Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition. Applied Health Economics and Health Policy, pp. 1-13. PubblicazioniPaolo Pertile
Vogler S., Pertile P., Gamba S. (2019). Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice. Journal of Pharmaceutical Policy and Practice, 12(3), 34. Non categorizzatoPaolo Pertile
